Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Últimos análisis de IA sobre Ligand Pharmaceuticals, Inc.
Sin cotización
Precio de cierre OTC 14.04.2026:
0,002 USD
14.04.2026 18:31
Cotizaciones actuales de Ligand Pharmaceuticals, Inc.
Bolsa
Ticker
Moneda
Última operación
Precio
Variación diaria
UTC
LGNXZ
USD
14.04.2026 18:31
0,002 USD
-
Perfil de la empresa para Ligand Pharmaceuticals, Inc. Acción
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.
